Select Publications

Journal articles

Pymm P; Adair A; Chan LJ; Cooney JP; Mordant FL; Allison CC; Lopez E; Haycroft ER; O'Neill MT; Tan LL; Dietrich MH; Drew D; Doerflinger M; Dengler MA; Scott NE; Wheatley AK; Gherardin NA; Venugopal H; Cromer D; Davenport MP; Pickering R; Godfrey DI; Purcell DFJ; Kent SJ; Chung AW; Subbarao K; Pellegrini M; Glukhova A; Tham WH, 2021, 'Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice', Proceedings of the National Academy of Sciences of the United States of America, 118, http://dx.doi.org/10.1073/pnas.2101918118

Okoye AA; Duell DD; Fukazawa Y; Varco-Merth B; Marenco A; Behrens H; Chaunzwa M; Selseth AN; Gilbride RM; Shao J; Edlefsen PT; Geleziunas R; Pinkevych M; Davenport MP; Busman-Sahay K; Nekorchuk M; Park H; Smedley J; Axthelm MK; Estes JD; Hansen SG; Keele BF; Lifson JD; Picker LJ, 2021, 'CD8+T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification', Journal of Clinical Investigation, 131, http://dx.doi.org/10.1172/JCI141677

Selva KJ; Davis SK; Haycroft ER; Lee WS; Lopez E; Reynaldi A; Davenport MP; Kent HE; Juno JA; Chung AW; Kent SJ, 2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', Clinical and Translational Immunology, 10, http://dx.doi.org/10.1002/cti2.1354

Cromer D; Reynaldi A; Steain M; Triccas J; Davenport M; Khoury D, 2021, 'Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial', , http://dx.doi.org/10.1101/2021.06.29.21259504

Cromer D; Steain M; Reynaldi A; Schlub T; Wheatley A; Juno J; Kent S; Triccas J; Khoury D; Davenport M, 2021, 'SARS-CoV-2 variants: levels of neutralisation required for protective immunity', , http://dx.doi.org/10.1101/2021.08.11.21261876

Selva K; Davis S; Haycroft E; Lee WS; Lopez E; Reynaldi A; Davenport M; Kent H; Juno J; Chung A; Kent S, 2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', , http://dx.doi.org/10.1101/2021.08.02.21261479

Khoury D; Cromer D; Reynaldi A; Schlub T; Wheatley A; Juno J; Subbarao K; Kent S; Triccas J; Davenport M, 2021, 'What level of neutralising antibody protects from COVID-19?', , http://dx.doi.org/10.1101/2021.03.09.21252641

Khoury DS; Wheatley AK; Ramuta MD; Reynaldi A; Cromer D; Subbarao K; O’Connor DH; Kent SJ; Davenport MP, 2020, 'Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models', Nature Reviews Immunology, 20, pp. 727 - 738, http://dx.doi.org/10.1038/s41577-020-00471-1

Soon MSF; Lee HJ; Engel JA; Straube J; Thomas BS; Pernold CPS; Clarke LS; Laohamonthonkul P; Haldar RN; Williams CG; Lansink LIM; Moreira ML; Bramhall M; Koufariotis LT; Wood S; Chen X; James KR; Lönnberg T; Lane SW; Belz GT; Engwerda CR; Khoury DS; Davenport MP; Svensson V; Teichmann SA; Haque A, 2020, 'Transcriptome dynamics of CD4+ T cells during malaria maps gradual transit from effector to memory', Nature Immunology, 21, pp. 1597 - 1610, http://dx.doi.org/10.1038/s41590-020-0800-8

Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ, 2020, 'Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood', ACS Nano, 14, pp. 15723 - 15737, http://dx.doi.org/10.1021/acsnano.0c06679

Khoury DS; Cao P; Zaloumis SG; Davenport MP, 2020, 'Artemisinin Resistance and the Unique Selection Pressure of a Short-acting Antimalarial', Trends in Parasitology, 36, pp. 884 - 887, http://dx.doi.org/10.1016/j.pt.2020.07.004

Juno JA; Tan HX; Lee WS; Reynaldi A; Kelly HG; Wragg K; Esterbauer R; Kent HE; Batten CJ; Mordant FL; Gherardin NA; Pymm P; Dietrich MH; Scott NE; Tham WH; Godfrey DI; Subbarao K; Davenport MP; Kent SJ; Wheatley AK, 2020, 'Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19', Nature Medicine, 26, pp. 1428 - 1434, http://dx.doi.org/10.1038/s41591-020-0995-0

Wu Y; Pinkevych M; Xu Z; Keele BF; Davenport MP; Cromer D, 2020, 'Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption', Proceedings of the Royal Society B: Biological Sciences, 287, http://dx.doi.org/10.1098/rspb.2020.0354

Davenport MP; Smith NL; Rudd BD, 2020, 'Building a T cell compartment: how immune cell development shapes function', Nature Reviews Immunology, 20, pp. 499 - 506, http://dx.doi.org/10.1038/s41577-020-0332-3

Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU, 2020, 'Quantifying and preventing plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil', PLoS Neglected Tropical Diseases, 14, pp. 1 - 16, http://dx.doi.org/10.1371/journal.pntd.0008526

Khoury DS; Zaloumis SG; Grigg MJ; Haque A; Davenport MP; Cromer D; Rebelo M; Cao P; McCaw JM; Simpson JA; Flegg JA; Wilson DW; Anstey NM; McCarthy JS, 2020, 'Malaria Parasite Clearance: What Are We Really Measuring?', Trends in Parasitology, 36, pp. 413 - 426, http://dx.doi.org/10.1016/j.pt.2020.02.005

Vanderven HA; Barr I; Reynaldi A; Wheatley AK; Wines BD; Davenport MP; Hogarth PM; Kent SJ, 2020, 'Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults', Vaccine, 38, pp. 2368 - 2377, http://dx.doi.org/10.1016/j.vaccine.2020.01.066

Immonen TT; Camus C; Reid C; Fennessey CM; Del Prete GQ; Davenport MP; Lifson JD; Keele BF, 2020, 'Genetically barcoded SIV reveals the emergence of escape mutations in multiple viral lineages during immune escape', Proceedings of the National Academy of Sciences of the United States of America, 117, pp. 494 - 502, http://dx.doi.org/10.1073/pnas.1914967117

Khanal S; Fennessey CM; O'Brien SP; Thorpe A; Reid C; Immonen TT; Smith R; Bess JW; Swanstrom AE; Del Prete GQ; Davenport MP; Okoye AA; Picker LJ; Lifson JD; Keele BF, 2020, 'In vivo validation of the viral barcoding of simian immunodeficiency virus SIVmac239 and the development of new barcoded SIV and subtype B and C simian-human immunodeficiency viruses', Journal of Virology, 94, http://dx.doi.org/10.1128/JVI.01420-19

Smith CJ; Venturi V; Quigley MF; Turula H; Gostick E; Ladell K; Hill BJ; Himelfarb D; Quinn KM; Greenaway HY; Dang THY; Seder RA; Douek DC; Hill AB; Davenport MP; Price DA; Snyder CM, 2020, 'Stochastic expansions maintain the clonal stability of CD8+ T cell populations undergoing memory inflation driven by murine cytomegalovirus', Journal of Immunology, 204, pp. 112 - 121, http://dx.doi.org/10.4049/jimmunol.1900455

Pinkevych M; Fennessey CM; Cromer D; Reid C; Trubey CM; Lifson JD; Keele BF; Davenport MP, 2019, 'Predictors of SIV recrudescence following antiretroviral treatment interruption', eLife, 8, http://dx.doi.org/10.7554/eLife.49022

Liu J; Hill BJ; Darko S; Song K; Quigley MF; Asher TE; Morita Y; Greenaway HY; Venturi V; Douek DC; Davenport MP; Price DA; Roederer M, 2019, 'The peripheral differentiation of human natural killer T cells', Immunology and Cell Biology, 97, pp. 586 - 596, http://dx.doi.org/10.1111/imcb.12248

Khoury DS; Cromer D; Möhrle JJ; McCarthy JS; Davenport MP, 2019, 'Corrigendum: Defining the effectiveness of antimalarial chemotherapy: Investigation of the lag in parasite clearance following drug administration (Journal of Infectious Diseases (2016) 214 (753-761) DOI: 10.1093/infdis/jiw234)', Journal of Infectious Diseases, 219, pp. 1852 - 1853, http://dx.doi.org/10.1093/infdis/jiy729

Kent SJ; Davenport MP, 2019, 'Moving the HIV vaccine field forward: concepts of protective immunity', The Lancet HIV, 6, pp. e406 - e410, http://dx.doi.org/10.1016/S2352-3018(19)30134-1

Akter J; Khoury DS; Aogo R; Lansink LIM; SheelaNair A; Thomas BS; Laohamonthonkul P; Pernold CPS; Dixon MWA; Soon MSF; Fogg LG; Engel JA; Elliott T; Sebina I; James KR; Cromer D; Davenport MP; Haque A, 2019, 'Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells', PLoS Pathogens, 15, http://dx.doi.org/10.1371/journal.ppat.1007599

Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP, 2019, 'Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants', Malaria Journal, 18, http://dx.doi.org/10.1186/s12936-019-2657-6

Parsons MS; Lee WS; Kristensen AB; Amarasena T; Khoury G; Wheatley AK; Reynaldi A; Wines BD; Hogarth PM; Davenport MP; Kent SJ, 2019, 'Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques', Journal of Clinical Investigation, 129, http://dx.doi.org/10.1172/JCI122466

Deleage C; Immonen TT; Fennessey CM; Reynaldi A; Reid C; Newman L; Lipkey L; Schlub TE; Camus C; O'Brien S; Smedley J; Conway JM; Del Prete GQ; Davenport MP; Lifson JD; Estes JD; Keele BF, 2019, 'Defining early SIV replication and dissemination dynamics following vaginal transmission', Science Advances, 5, http://dx.doi.org/10.1126/sciadv.aav7116

Reynaldi A; Smith NL; Schlub TE; Tabilas C; Venturi V; Rudd BD; Davenport MP, 2019, 'Fate mapping reveals the age structure of the peripheral T cell compartment', Proceedings of the National Academy of Sciences of the United States of America, 116, pp. 3974 - 3981, http://dx.doi.org/10.1073/pnas.1811634116

Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ, 2019, 'Functional cure of HIV: the scale of the challenge', Nature Reviews Immunology, 19, pp. 45 - 54, http://dx.doi.org/10.1038/s41577-018-0085-4

Charon J; Grigg MJ; Eden JS; Piera KA; Rana H; William T; Rose K; Davenport MP; Anstey NM; Holmes EC, 2019, 'Novel RNA viruses associated with Plasmodium vivax in human malaria and Leucocytozoon parasites in avian disease', PLoS Pathogens, 15, http://dx.doi.org/10.1371/journal.ppat.1008216

Stern J; Roche M; Solomon A; Dantanarayana A; Reynaldi A; Davenport M; Deeks SG; Hartogenesis W; Hecht FM; Cockerham L; Lewin SR, 2019, 'Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy', Journal of Virus Eradication, 5, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)31037-2

Pino M; King C; Shim I; Wang H; Nguyen K; Samer S; Harper J; Lifson J; Reynaldi A; Deleage C; Padhan K; Cervasi B; Davenport MP; Petrovas C; Lederman MM; Paiardini M, 2019, 'Fingolimod treatment at ART initiation delays SIV rebound after ART interruption', Journal of Virus Eradication, 5, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)31078-5

Betts M; Kuri Cervantes L; Pampena MB; Samer S; Khoury D; Frank I; Paiardini M; Davenport M; Bar K; Veazey R, 2019, 'Peripheral blood SIV/HIV originates from infected cells in tissues', Journal of Virus Eradication, 5, pp. 27 - 27, http://dx.doi.org/10.1016/s2055-6640(20)30142-4

Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA, 2018, 'In silico investigation of the decline in clinical efficacy of artemisinin combination therapies due to increasing artemisinin and partner drug resistance', Antimicrobial Agents and Chemotherapy, 62, http://dx.doi.org/10.1128/AAC.01292-18

Aogo RA; Khoury DS; Cromer D; Elliott T; Akter J; Fogg LG; Nair AS; Liligeto UN; Soon MSF; Thomas BS; Pernold CPS; Romanczuk AS; Laohamonthonkul P; Haque A; Davenport MP, 2018, 'Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice', International Journal for Parasitology, 48, pp. 903 - 913, http://dx.doi.org/10.1016/j.ijpara.2018.05.010

Khoury DS; Aogo R; Randriafanomezantsoa-Radohery G; McCaw JM; Simpson JA; McCarthy JS; Haque A; Cromer D; Davenport MP, 2018, 'Within-host modeling of blood-stage malaria', Immunological Reviews, 285, pp. 168 - 193, http://dx.doi.org/10.1111/imr.12697

Smithey MJ; Venturi V; Davenport MP; Buntzman AS; Vincent BG; Frelinger JA; Nikolich-Žugich J, 2018, 'Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection', Proceedings of the National Academy of Sciences of the United States of America, 115, pp. E6817 - E6825, http://dx.doi.org/10.1073/pnas.1719451115

Smith NL; Patel RK; Reynaldi A; Grenier JK; Wang J; Watson NB; Nzingha K; Yee Mon KJ; Peng SA; Grimson A; Davenport MP; Rudd BD, 2018, 'Developmental Origin Governs CD8+ T Cell Fate Decisions during Infection', Cell, 174, pp. 117 - 130.e14, http://dx.doi.org/10.1016/j.cell.2018.05.029

Parsons MS; Cromer D; Davenport MP; Kent SJ, 2018, 'HIV Reactivation after Partial Protection by Neutralizing Antibodies', Trends in Immunology, 39, pp. 359 - 366, http://dx.doi.org/10.1016/j.it.2017.12.006

Aliota MT; Dudley DM; Newman CM; Weger-Lucarelli J; Stewart LM; Koenig MR; Breitbach ME; Weiler AM; Semler MR; Barry GL; Zarbock KR; Haj AK; Moriarty RV; Mohns MS; Mohr EL; Venturi V; Schultz-Darken N; Peterson E; Newton W; Schotzko ML; Simmons HA; Mejia A; Hayes JM; Capuano S; Davenport MP; Friedrich TC; Ebel GD; O’Connor SL; O’Connor DH, 2018, 'Molecularly barcoded Zika virus libraries to probe in vivo evolutionary dynamics', PLoS Pathogens, 14, http://dx.doi.org/10.1371/journal.ppat.1006964

Pinkevych M; Fennessey CM; Cromer D; Tolstrup M; Søgaard OS; Rasmussen TA; Keele BF; Davenport MP, 2018, 'Estimating initial viral levels during simian immunodeficiency virus/human immunodeficiency virus reactivation from latency', Journal of Virology, 92, http://dx.doi.org/10.1128/JVI.01667-17

Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP, 2017, 'Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo', International Journal for Parasitology, 47, pp. 913 - 922, http://dx.doi.org/10.1016/j.ijpara.2017.05.009

Cromer D; Pinkevych M; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP, 2017, 'Modeling of antilatency treatment in HIV: What is the optimal duration of antiretroviral therapy-free HIV remission?', Journal of Virology, 91, http://dx.doi.org/10.1128/JVI.01395-17

Lloyd SB; Niven KP; Kiefel BR; Montefiori DC; Reynaldi A; Davenport MP; Kent SJ; Winnall WR, 2017, 'Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV', Human Vaccines and Immunotherapeutics, 13, pp. 2726 - 2737, http://dx.doi.org/10.1080/21645515.2017.1368935

Cao P; Klonis N; Zaloumis S; Khoury DS; Cromer D; Davenport MP; Tilley L; Simpson JA; McCaw JM, 2017, 'A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection', Journal of Theoretical Biology, 430, pp. 117 - 127, http://dx.doi.org/10.1016/j.jtbi.2017.07.017

Parsons MS; Lloyd SB; Lee WS; Kristensen AB; Amarasena T; Center RJ; Keele BF; Lifson JD; La Branche CC; Montefiori D; Wine BD; Hogarth PM; Swiderek KM; Venturi V; Davenport MP; Kent SJ, 2017, 'Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection', Science Translational Medicine, 9, http://dx.doi.org/10.1126/scitranslmed.aaf1483

Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Mark Hogarth P; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ, 2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, 91, http://dx.doi.org/10.1128/JVI.00603-17

Khoury DS; Cromer D; Akter J; Sebina I; Elliott T; Thomas BS; Soon MSF; James KR; Best SE; Haque A; Davenport MP, 2017, 'Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection', Proceedings of the National Academy of Sciences of the United States of America, 114, pp. 7701 - 7706, http://dx.doi.org/10.1073/pnas.1618939114

Vanderven HA; Liu L; Ana-Sosa-Batiz F; Nguyen THO; Wan Y; Wines B; Mark Hogarth P; Tilmanis D; Reynaldi A; Parsons MS; Hurt AC; Davenport MP; Kotsimbos T; Cheng AC; Kedzierska K; Zhang X; Xu J; Kent SJ, 2017, 'Fc functional antibodies in humans with severe H7N9 and seasonal influenza', Journal of Clinical Investigation, 2, http://dx.doi.org/10.1172/jci.insight.92750


Back to profile page